Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Qiming Venture Partners USA, founded in January 2017, is the first US team and fund of the China-based Qiming Venture Partners. The firm has raised $550 million across three funds and manages over 30 portfolio companies. Offices are located in Cambridge, Seattle, and San Francisco, providing a strong presence in key innovation hubs.
This firm invests in early-stage healthcare opportunities, particularly in the United States and Europe. They target pre-seed to Series A stages, focusing on disruptive therapies and digital health solutions. Check sizes typically align with early-stage funding requirements, supporting entrepreneurs in building transformative healthcare companies.
Notable companies in Qiming Venture Partners USA's portfolio include various healthcare startups, with the firm participating in 11 mergers and acquisitions and initial public offerings. Specific company names are not disclosed in the source material.
Submit your pitch through their website's contact form for consideration.
Yes, Qiming Venture Partners USA often leads investment rounds, particularly in early-stage healthcare companies.
The firm actively considers follow-on investments to support portfolio companies as they grow and scale.
The firm has raised a total of $550 million across three funds since its inception.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.